Outer membrane protein ospC is essential for the invasive strategy of the pathogenic spirochete responsible for Lyme disease. Detection of anti-OspC borreliacidal antibodies, especially IgM antibodies, in early Lyme borreliosis sera provides additional evidence that borreliacidal antibody detection may be useful for the serodiagnosis of early Lyme borreliosis.
FOR RESEARCH ANDCOMERCIAL USE IVD ONLY (*)
(*) Our biomarkers are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our biomarkers, you can visit here.